Loading...
XHKG
0575
Market cap1mUSD
Jul 09, Last price  
0.94HKD
1D
-1.05%
1Q
34.29%
Jan 2017
-92.03%
Name

Endurance RP Ltd

Chart & Performance

D1W1MN
XHKG:0575 chart
P/E
P/S
96.44
EPS
Div Yield, %
Shrs. gr., 5y
22.97%
Rev. gr., 5y
-26.30%
Revenues
363k
-49.51%
4,175,0003,684,0006,142,00020,553,0005,332,0004,669,0005,890,0002,670,000-10,000212,000137,0005,232,0006,120,000628,0001,670,0003,254,000114,000382,000719,000363,000
Net income
-5m
L+5.09%
8,134,000612,000-160,943,00011,052,00059,792,000-48,527,000-44,854,000-25,636,000-8,563,000-9,333,000-2,460,000-27,359,000-31,087,000-65,999,000-24,396,000-12,598,000-36,427,000-25,049,000-4,482,000-4,710,000
CFO
-4m
L+4.25%
-7,297,000-4,430,000-41,095,000-15,219,000-36,407,000-73,587,000-6,130,00052,654,000-3,984,000-7,732,000-8,307,000-2,747,000-1,882,000-9,038,000-5,721,000-1,703,000506,000-3,590,000-4,129,000-4,304,357
Dividend
Feb 08, 20130.0007 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Endurance RP Limited functions as an investment holding company, concentrating its investments within the healthcare and life sciences sectors across the People's Republic of China, Europe, Hong Kong, and Taiwan. The firm organizes its activities into two primary divisions: Biopharma and Corporate Investment. The Biopharma segment is responsible for the research, development, production, promotion, and distribution of pharmaceutical products aimed at addressing and managing urological disorders. This division also innovates artificial intelligence systems to precisely track the pace of aging, examining it at molecular, cellular, tissue, organ, systemic, physiological, and psychological levels. Through its Corporate Investment division, the company strategically invests in both publicly traded and privately held corporate entities. Additionally, it extends its services to include management consulting and corporate financial advice. Incorporated in 1991 and headquartered in Central, Hong Kong, Endurance RP Limited adopted its current name in June 2021, having previously operated as Regent Pacific Group Limited.
IPO date
May 19, 1997
Employees
20
Domiciled in
HK
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT